(Q33148945)

22 July 2017

title

Implantable cardioverter defibrillator in high-risk long QT syndrome patients (English)

1 reference

22 July 2017

1 reference

1 reference

1

Wojciech Zareba

1 reference

22 July 2017

3

James P Daubert

1 reference

22 July 2017

2

Arthur J Moss

1 reference

22 July 2017

4

W Jackson Hall

1 reference

22 July 2017

Jennifer L Robinson

5

1 reference

22 July 2017

Mark Andrews

series ordinal

6

1 reference

22 July 2017

publication date

1 April 2003

1 reference

Journal of Cardiovascular Electrophysiology

22 July 2017

published in

1 reference

22 July 2017

volume

14

1 reference

22 July 2017

issue

4

1 reference

22 July 2017

page(s)

337-341

1 reference

The long QT syndrome. Prospective longitudinal study of 328 families

22 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.02545.X

Diagnostic criteria for the long QT syndrome. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.02545.X

Influence of the genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.02545.X

Risk of cardiac events in family members of patients with long QT syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.02545.X

The idiopathic long QT syndrome: pathogenetic mechanisms and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.02545.X

Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.02545.X

Efficacy of permanent pacing in the management of high-risk patients with long QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.02545.X

Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.02545.X

Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.02545.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.02545.X

Implantable cardioverter-defibrillators in children: a single-institutional experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.02545.X

Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.02545.X

Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1540-8167.2003.02545.X

10.1046/J.1540-8167.2003.02545.X

21 January 2018

Identifiers

DOI

1 reference

22 July 2017

1 reference